SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has expanded its international footprint with the launch of Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo. The program is powered by the company's SSi Mantra 3.0 surgical robotic system and began with a robotic-assisted left internal mammary artery takedown performed by company founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. According to the announcement, the hospital completed more than 25 robotic procedures within the first three weeks, demonstrating rapid adoption of the technology.
The launch matters because it adds to SS Innovations' growing international expansion and provides further validation of its strategy to make robotic surgery more affordable and accessible. At the end of the second quarter of 2026, the company reported 224 cumulative SSi Mantra installations across 12 countries. Quarterly revenue increased 39% year over year to $13.9 million, while robotic procedures rose 143% to 2,528. That procedure growth outpaces installation growth, indicating increased utilization of installed systems and potential opportunities for recurring revenue from surgical instruments and consumables. For investors, the Sri Lanka program signals that the company is not only selling systems but also driving clinical adoption in new markets.
SS Innovations is also pursuing broader market access, with U.S. FDA clearance targeted for the first quarter of 2027 and European CE marking targeted for the end of 2026. Those regulatory milestones could significantly expand the company's addressable market. The company's product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. More information is available at SSInnovations.com, and the full article can be viewed at https://nnw.fm/DJ6dI. The latest news and updates relating to SSII are available in the company's newsroom at https://nnw.fm/SSII.
The announcement was distributed through NetworkNewsWire, a specialized communications platform focused on financial news and content distribution. NNW is one of more than 75 brands within the Dynamic Brand Portfolio at IBN, which provides wire solutions via InvestorWire, editorial syndication to more than 5,000 outlets, press release enhancement, social media distribution, and corporate communications solutions. The platform's reach is designed to help companies like SS Innovations reach a wide audience of investors, influencers, consumers, journalists, and the general public. Full terms of use and disclaimers are available at https://www.NetworkNewsWire.com/Disclaimer.
